![Mark Never](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Never worked as a Director at Camurus AB, Head-Cluster Western Europe at Novartis AG, and Country President & Head-Purchasing at both Sandoz Deutschland GmbH and Elanco Italia SpA. He holds an MBA from Cranfield University.
| Unternehmen | Position | Ende |
|---|---|---|
Elanco Italia SpA
 Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Sandoz Deutschland GmbH
 Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | - |
| CAMURUS AB | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Cranfield University
 Cranfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camurus AB
 Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
Sandoz Deutschland GmbH
Sandoz Deutschland GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Elanco Italia SpA
Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
